P Dahm, M Brasure, R MacDonald, CM Olson… - European urology, 2017 - Elsevier
Abstract Context Alpha-blockers (ABs) and 5-alpha reductase inhibitors have an established
role in treating male lower urinary tract symptoms (LUTS) attributed to benign prostatic …